SCOTTSDALE, AZ / ACCESSWIRE / January 27, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces 2 New Products from its Hemp Facility.
The first product CBD Life Sciences Inc. is working with is Delta 8 Gummies (Tropical Mix). A delta 8 gummy is a gummy infused with delta 8 distillate. These gummies are preferred due to having most of the benefits of delta 9 THC without the psychoactive impairment. Delta 8 gummies are known as the „functional” person’s gummies. Unlike CBD gummies, you may feel a mild and relaxing high without the anxiousness sometimes experienced with Delta-9 THC. These gummies are sure to please anyone who likes a little kick!
Another product CBD Life Sciences Inc. is working with is Delta 8 Rechargeable Vapes coming in two different flavors. One being Apple Fritter & the other one being Grape Ape. Delta-8-THC products are exploding in popularity, as people look to enjoy a completely legal marijuana-style high. And with one of our Delta-8-THC Vape Cartridges, you can do just that! Delta-8-THC Vape Cartridges contain rich levels – 900mg in this case – of delta-8-THC. This compound is a legal cannabinoid from the hemp plant, that bears a close resemblance to the psychoactive and federally prohibited delta-9-THC. Delta-8-THC induces a mild psychoactive high, making it popular for recreational use, and potentially for therapeutic use. President & CEO, Lisa Nelson states „Adding Delta 8 Products to our existing inventory is going to be huge since we already have a variety as it is”! „This is a wonderful opportunity for overall growth, expansion, and increased revenue”.
CBD Life Sciences Inc. has already identified several potential cultivation sites and is aggressively pursuing amazing new opportunities in Arizona’s new recreational cannabis market. This new law gives CBD Life Sciences Inc. the capability of offering licensed retailers CBD Life Sciences Inc. premium cannabis products which are then made available for sale to 1000’s of future recreational cannabis customers in addition to current cannabis sales to existing medical-use dispensaries in Arizona.
Video Link to Facility: https://streamable.com/btidfe
Video 2 Link to Facility: https://streamable.com/fxrext
The number of benefits CBD has is tremendous! These benefits include help with behavioral/neurological complications such as ADD/ADHD, anxiety, bipolar, OCD, PTSD, epilepsy, Parkinson’s, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn’s, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings – all at very reasonable prices. Check out LBC Bioscience Inc’s newest product offerings including its: 100mg CBD Bath Bombs, CBD Flower, CBD Hemp Smokes, 1500 MG Premium Berry Drops, 100MG CBD Tablets and our tasty CBD Gumballs. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
Why Shop LBC Bioscience?
Large Selection of Products (over 50 items and growing)
100% USA Made Products „organic & kosher.”
30% off on all products using code „LBC30”
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc’s Main Website at www.lbcbioscienceinc.com
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC’s products can be viewed and purchased on the Company’s website at www.lbcbioscienceinc.com.
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc’s, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com: